STAGE II PANCREATIC CANCER

Clinical trials for STAGE II PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new STAGE II PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for STAGE II PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Pancreatic cancer drug combo trial halted early

Disease control Terminated

This early-stage trial tested a combination of two drugs, trametinib and hydroxychloroquine, in 25 adults with advanced pancreatic cancer that could not be removed by surgery. The goal was to find the safest dose and check for side effects. The study was terminated early, so resu…

Matched conditions: STAGE II PANCREATIC CANCER

Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control

Last updated May 17, 2026 06:14 UTC

STAGE II PANCREATIC CANCER

Get alerted when new STAGE II PANCREATIC CANCER trials appear

Pancreatic cancer drug combo trial halted early